Theravance Biopharma (TBPH) Gross Margin (2013 - 2018)
Theravance Biopharma's (TBPH) quarterly Gross Margin came in at 95.98% in Q4 2018, up 4693.0% year-on-year from 2.0% in Q4 2017, and up 1.56% on a QoQ basis from 94.51% in Q3 2018.
Theravance Biopharma (TBPH) Gross Margin (2013 - 2018) Analysis & Trends
Theravance Biopharma (TBPH) has 6 years of Gross Margin data on file, last reported at 95.98% in Q4 2018.
- On a quarterly basis, Gross Margin rose 4693.0% year-over-year to 95.98% in Q4 2018; TTM through Dec 2018 was 94.02%, a 2791.0% increase from a year earlier, with the FY2018 full-year figure at 98.82%, up 3801.0% from the prior year.
- Gross Margin for Q4 2018 stood at 95.98%, up from 94.51% in the prior quarter.
- Over the last five years, Gross Margin for TBPH reached as high as 98.26% in Q3 2016 and fell as low as 124.84% in Q4 2014.
- Historically, Gross Margin has averaged 72.82% across 5 years, with a median of 91.77% in 2014.
- Across the five-year window, Gross Margin slumped 22484 bps in 2014 and surged 14262 bps in 2015, its largest moves.
- Year by year, Gross Margin stood at 124.84% in 2014, then soared by 114 bps to 17.78% in 2015, then jumped by 349 bps to 79.87% in 2016, then plunged by 39 bps to 49.06% in 2017, then surged by 96 bps to 95.98% in 2018.
- Per Business Quant data, the three most recent Gross Margin figures were 95.98% in Q4 2018, 94.51% in Q3 2018, and 93.83% in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 95.98% |
| Sep 30, 2018 | 94.51% |
| Jun 30, 2018 | 93.83% |
| Mar 31, 2018 | 90.07% |
| Dec 31, 2017 | 49.06% |
| Sep 30, 2017 | 76.96% |
| Jun 30, 2017 | 61.13% |
| Mar 31, 2017 | 81.70% |
| Dec 31, 2016 | 79.87% |
| Sep 30, 2016 | 98.26% |
| Jun 30, 2016 | 95.75% |
| Mar 31, 2016 | 95.77% |
| Dec 31, 2015 | 17.78% |
| Sep 30, 2015 | 94.57% |
| Jun 30, 2015 | 92.92% |
| Mar 31, 2015 | 98.18% |
| Dec 31, 2014 | -124.84% |
| Sep 30, 2014 | 94.18% |
| Jun 30, 2014 | 90.62% |
| Mar 31, 2014 | 80.11% |